title: Oral health after breast cancer treatment in postmenopausal women.
abstract: OBJECTIVE
  Oral health can affect a patient's general health and quality of life. Given the increase in breast cancer survival rates, investigations of factors influencing the quality of life of survivors have gained importance. Therefore, the objective of our study was to characterize oral health in postmenopausal breast cancer survivors.
  
  
  METHODS
  We conducted a matched case-control study. Forty-eight women who survived breast cancer (age 62.1±9.1 years) and 48 healthy controls (age 61.8±8.6 years) were included. For each case and control, a complete oral evaluation chart was completed.
  
  
  RESULTS
  The prevalence of chronic periodontal disease was 98% in breast cancer survivors and 87% in controls. The breast cancer survivors had a median of 16 remaining teeth, whereas controls had a median of 22 remaining teeth (p = 0.03). The percentage of sites with gingival bleeding was 16.05% (0-100%) in breast cancer survivors and 0% (0-72%) in controls (p = 0.04).
  
  
  CONCLUSIONS
  Chronic periodontal disease and tooth loss were highly prevalent in postmenopausal breast cancer survivors. To improve survivors' quality of life, a preventive oral health evaluation should be available prior to cancer treatment.
authors.affiliation: Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
authors.forename: Juliana
authors.initials: J
authors.lastname: Amódio
authors.affiliation: Departamento de Cirurgia e Traumatologia Buco-Maxilo-Facial e Periodontia, Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
authors.forename: Daniela Bazan
authors.initials: DB
authors.lastname: Palioto
authors.affiliation: Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
authors.forename: Helio Humberto Angotti
authors.initials: HH
authors.lastname: Carrara
authors.affiliation: Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
authors.forename: Daniel Guimaraes
authors.initials: DG
authors.lastname: Tiezzi
authors.affiliation: Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
authors.forename: Jurandyr Moreira de
authors.initials: JM
authors.lastname: Andrade
authors.affiliation: Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
authors.forename: Francisco José Candido Dos
authors.initials: FJ
authors.lastname: Reis
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects; D001943:Breast Neoplasms / Q000150:complications / Q000628:therapy*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008875:Middle Aged; D009909:Oral Health; D010512:Periodontal Index; D010518:Periodontitis / Q000453:epidemiology* / Q000209:etiology; D017698:Postmenopause; D015995:Prevalence; D011788:Quality of Life; D011878:Radiotherapy / Q000009:adverse effects; D018709:Statistics, Nonparametric; D017741:Survivors / Q000706:statistics & numerical data*; D016388:Tooth Loss / Q000209:etiology
chemical_list: D000970:Antineoplastic Agents